<DOC>
	<DOC>NCT01527383</DOC>
	<brief_summary>This is a randomized, double-blind, placebo-controlled study to assess the safety and tolerability of V212 when administered to adults with autoimmune disease.</brief_summary>
	<brief_title>A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009)</brief_title>
	<detailed_description>This is a randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and immunogenicity of V212 vaccine in adults with autoimmune disease, including patients with rheumatoid arthritis, psoriatic arthritis, psoriasis, inflammatory bowel disease, systemic lupus erythematosus, multiple sclerosis, and other similar diseases.</detailed_description>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Autoimmune Diseases</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Diagnosed with an autoimmune disease Clinically stable disease for at least 30 days before enrollment Not likely to undergo hematopoietic stem cell transplantation during the study period Receiving at least one parenteral or oral biologic agent, such as a TNF alpha inhibitor, or a parenteral or oral nonbiologic therapy, at a stable dose for at least 3 months, with no planned or anticipated changes History of varicella, antibodies to VZV, or residence for at least 30 years in a country with endemic VZV infection, or if participant is less than 30 years old, attended primary or secondary school in a country with endemic VZV infection Prior history of Herpes Zoster (shingles) within 1 year before enrollment Prior varicella or zoster vaccine Active central nervous system lupus erythematosus requiring therapeutic intervention within 90 days of enrollment Prior or planned therapy containing rituximab or other antiCD20 monoclonal antibodies from 3 months before enrollment through 28 days postdose 4 Systemic corticosteroid therapy, prednisone, or equivalent over 40 mg daily at the time of enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Shingles</keyword>
</DOC>